1.Detection of primary sites of unknown primary tumors using 18F-FDG PET-CT
Cancer Research and Clinic 2012;24(1):46-48
Objective To determine the value of 18F-FDG PET-CT in detecting the primary origin of cancer of unknown primary (CUP).Methods A total of 48 patients (age range 41-82 years,mean age of 57±16 years, 20 females) were retrospectively selected. All patients were diagnosed as CUP and were examined by 18F-FDG PET-CT scan.The patients were divided into cervical lymph node metastasis group (28 cases) and extra-cervical lymph node metastasis group (20 cases) according to different metastasis site.Sensitivity of 18F-FDG PET-CT to detect primary tumor site was compared between these two groups.Results 18F-FDG PET-CT detected primary tumors in 32 of 48 patients (66.7 %), the cervical lymph node metastasis tumors in 22 of 28 patients (78.6 %), and extra-cervical lymph node metastasis tumors in 10 of 20 patients (50.0 %).There was significant difference between cervical lymph node metastasis group and extra-cervical lymph node metastasis group (x2 =4.286,P < 0.05).Conclusion 18F-FDG PET-CT has a high sensitivity to detect primary origin of CUP,especially for patients with cervical lymph node metastasis.
2. Stability of rh-endostatin and fabrication/release test of rh-endostatin loaded PLGA microspheres
Academic Journal of Second Military Medical University 2010;30(1):28-31
Objective: To prepare rh-endostatin loaded poly (lactic-co-gtycolic acid) (PLGA) microspheres and to evaluate their release behavior in vitro. Methods: Rh-endostatin PLGA microspheres were prepared by W/O/W process. The content and in vitro cumulative release was determined by a HPLC method. Results: The prepared microspheres were well-shaped, with a mean diameter of 122.7 μm. The drug loading and encapsulation efficiency were 1.28% and 38.65%, respectively. The rh-Endo solution (250 μg/ml) showed good stability after placed at 4°C and 25°C for 108 h. The cumulative in vitro release was up to 67.37% in 28 days. Conclusion: The rh-Endo can be encapsulated in microspheres to yield sustained release using biodegradable polymers PLGA as the carrier material.
3.Establishment of quality standard for Tibetan medicineRuyi-Zhenbao pill
Yanan HAN ; Ming YUAN ; Juan ZHOU ; Juan WANG
International Journal of Traditional Chinese Medicine 2017;39(1):53-58
Objective To establish a quality standard for Tibetan medicineRuyi-Zhenbao pill. Methods Thin-layer chromatography (TLC) was applied to identify 12 Tibetan medicinal materials, and High performance liquid chromatography (HPLC) was employed to determine the contents of gallic acid, dehydrodiisoeugenol, piperine, and cinnamaldehyde.Results The identified characteristics of TLC were distinct and the spots were clear. Linearity of gallic acid, dehydrodiisoeugenol, piperine, and cinnamaldehyde were in the range of 0.106-0.901μg, 0.033-0.281μg, 0.007-0.060μg, and 0.021-0.178μg, respectively. Average recovery was in the range of 98.47%-101.65% (RSD<3.0%).Conclusions The method of identification and content determination was good in terms of specificity, accuracy and repeatability, and can be used for quality control ofRuyi-Zhenbaopill.
6.Discussion on the application of rules of transfer of learning in medical innovative education
Xiaosong HU ; Xia WANG ; Juan LI ; Ming ZHANG
Chinese Journal of Medical Education Research 2011;10(4):398-400
In this article,from the view of the cognitive structure,we talk about the role of transfer of learning in medical innovative education,and propose the strategies on how to increase the positive transfer of learning through the rational organization of teaching contents,improved teaching methods,highlighting the dominant status of student to raise innovative talents.
7.Study on Aorui Gel in Preventing Esophageal Mucosa from Injury in Reflux Esophagitis Rats
Xiaoxiao WANG ; Ming WEI ; Fei DUAN ; Juan LIU
Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-
Objective To observe protective and repairing effect of Aorui Gel on esophageal mucosa injury in reflux esophagitis rats. Methods Rat models of reflux esophagitis were established by partial pylori ligation plus cardiomyotomy. Model control group,low-,middle-and high-dose Aorui Gel groups,positive control group,excipient control group and sham operation group were set up. Rats were treated with the corresponding drugs 7 days after operation. After treatment for 14 days,the rats'general state,and macroscopic features and pathological features of esophageal mucosa were compared. Results Macroscopic features and pathological features of esophageal mucosa in Aorui Gel groups differed from those in the model control group,inflammation of esophageal mucosa in Aorui Gel groups was alleviated,and pathological features were relieved and arrived to the normal state. Conclusion Aorui Gel can alleviate esophageal mucosa injury in reflux esophagitis rats,indicating that Aorui Gel has protective and repairing effect on esophageal mucosa injury.
9.A survey of iodine nutritional status in the populations of Guizhou Province after implementation of a new standard of salt iodine
Juan WANG ; Demei ZHOU ; Yu YANG ; Ming LIU ; Dancheng YAO
Chinese Journal of Endemiology 2016;35(4):283-286
Objective To investigate the iodine nutritional status in the populations of Guizhou Province after implementation of a new standard of salt iodine and to provide a basis in formulating strategy for control of iodine deficiency disorders.Methods In 2011 and 2014,30 units were sampled in Guizhou Province using the sampling method of Probability Proportional to Size.One primary school was chosen in each unit,by the randomized sampling method,40 or 50 students in each school were sampled for examining their urinary iodine level and for testing their household salt iodine level;12 and 50 children were chosen before and after the adjustment,respectively,for testing their urinary iodine level;near the location of the primary school,1 township was chosen,15-20 pregnant women in each township were sampled to test their urinary iodine level.Results Totally 1215 salt samples were collected before adjustment,the median of salt iodine was 32.2 mg/kg;consumption rate of qualified salt was 96.63%;totally 364 urine samples of 8-10 children were collected,the median of urinary iodine (MUI)of children was 308.9 μg/L;450 urine samples of pregnant women were sampled,and their MUI was 216.5 μg/L,among these,121 below 150 μg/L,the proportion was 26.9%.Totally 1 538 salt samples were collected after the adjustment,the median of salt iodine was 26.6 mg/kg;consumption rate of qualified salt was 96.40%;totally 1538urinary samples of 8-10 children were collected,the MUI of children was 218.3 μg/L;and 601 urinary samples of pregnant women were collected,the MUI was 175.1μg/L,among these,241 below 150 μg/L,the proportion was 40.1%.As can be seen from the results,the percentage of sample below 150 μg/L after the adjustment was increased to 13.2% compared to that before the adjustment,the difference was statistically significant (x2 =19.89,P <0.01).Conclusion After implementation of a new standard of salt iodine in Guizhou Province,the iodine nutrition is suitable in residents,but the iodine nutrition of pregnant women is in a trend of declining,which should be noticed.
10.Effect of treatment by bortezomib together with dexamethsone to the refractory multiple myeloma
Juan HE ; Jie LI ; Xiaoyi Lü ; Baixun WANG ; Ming ZHAI
Journal of Leukemia & Lymphoma 2008;17(5):359-360
Objective To analyze the effect of bortezomib together with dexamethsone on the treatment of refractory multiple myeloma.Methods Bortezomib at 1.3 mg/m2 iv drop 1 d,4 d,8 d,11 d.Dexamethasonc 20 mg/d,1~4 d,8~11 d,17~20 d.21 days are used as a course.For bi-course dexamethasone was given by 20 mg/d,at 1~4 d.Results After 2~6 periods,3 cases achieved completely recovery(CR),4 cases are near to completely recovery(CR),3 cases got partially recovery(PR).Conclusion It is a good choice to treat refractory multiple myeloma by Bortezomib together with dexamethagone.